{'text': "European Commission Approves Amgen's IMLYGIC™ (talimogene laherparepvec) As First Oncolytic Immunotherapy In Europe", 'publisher': {'href': 'https://www.amgen.com', 'title': 'Amgen'}, 'created_at': 'Thu, 17 Dec 2015 08:00:00 GMT', 'description': "European Commission Approves Amgen's IMLYGIC™ (talimogene laherparepvec) As First Oncolytic Immunotherapy In Europe  Amgen", 'url': 'https://news.google.com/rss/articles/CBMi-AFBVV95cUxOLUtlYmF6aGpHTTlfRXAweGpBQngyZFcxNDBMT2RxNHFLOVlGS3I2bHFIa3BhLVBUVlBVd3VqSS1DMHFFbGhISk55Qi1jLUN4cEhQWk5CRmp4cFF5VzN2NkFBWTRrTTFIcDVPVjRHRnVBLVJQQWVpZnJObmJHYm90V3Z5T241dVp0N0FHNjRFTW9GMWtqVGVFYThNQktaZTNHalJvMWVPYWVtQVpDcDMxREozenJ1U1NhdlprenkzVVQ3LUFwWGEydjRVUFRfMlZLbk5DVFNRS3lvMlJsNlFsc2t1ODBmVmFUcEJhU252VzRoNWRiZkh6RA?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Oakland biohackers beat funding goal for open source insulin protocol', 'publisher': {'href': 'https://oaklandnorth.net', 'title': 'Oakland North'}, 'created_at': 'Fri, 18 Dec 2015 08:00:00 GMT', 'description': 'Oakland biohackers beat funding goal for open source insulin protocol  Oakland North', 'url': 'https://news.google.com/rss/articles/CBMiqgFBVV95cUxQYjlWVjd1OGlqOC1VSmlydWY5dHNwN2xuVjlHcm82ZFRfajFRSEJKTDdPZDVDeDRuRHVYQmczRHJUSVl1bHJnNHpmTUgxbk9aRXBUSzZBX3diN1JpRW9wU0FZbG5CV1owX0h2dzNNZllPWS1reFh5VkhfWG1fVEpNZmJYbFNmNGNJamVuMnlIZnByN1U0SmVZRXZpY1p5MkdzWFhhR2g0V2JsUQ?oc=5&hl=en-SG&gl=SG&ceid=SG:en'}
